000 01229 a2200349 4500
005 20250512230948.0
264 0 _c19840709
008 198407s 0 0 eng d
022 _a0031-3955
024 7 _a10.1016/s0031-3955(16)34584-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRaskin, L A
245 0 0 _aNeurochemical correlates of attention deficit disorder.
_h[electronic resource]
260 _bPediatric clinics of North America
_cApr 1984
300 _a387-96 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAttention Deficit Disorder with Hyperactivity
_xdrug therapy
650 0 4 _aChild
650 0 4 _aDextroamphetamine
_xtherapeutic use
650 0 4 _aDopamine
_xmetabolism
650 0 4 _aHumans
650 0 4 _aMethoxyhydroxyphenylglycol
_xmetabolism
650 0 4 _aMethylphenidate
_xtherapeutic use
650 0 4 _aNorepinephrine
_xmetabolism
650 0 4 _aSerotonin
_xmetabolism
700 1 _aShaywitz, S E
700 1 _aShaywitz, B A
700 1 _aAnderson, G M
700 1 _aCohen, D J
773 0 _tPediatric clinics of North America
_gvol. 31
_gno. 2
_gp. 387-96
856 4 0 _uhttps://doi.org/10.1016/s0031-3955(16)34584-9
_zAvailable from publisher's website
999 _c6728303
_d6728303